Timothy Cowper
Finanzdirektor/CFO bei VERNALIS
Vermögen: 229 252 $ am 30.04.2024
Aktive Positionen von Timothy Cowper
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Direktor/Vorstandsmitglied | 01.01.2012 | - |
| Geschäftsführer | 22.01.2024 | - | |
| Finanzdirektor/CFO | 01.01.2012 | 22.01.2024 | |
| VERNALIS | Finanzdirektor/CFO | - | - |
Karriereverlauf von Timothy Cowper
Ehemalige bekannte Positionen von Timothy Cowper
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Sterilox Medical Ltd. | Comptroller/Controller/Auditor | - | - |
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Comptroller/Controller/Auditor | - | - |
Statistik
International
| Vereinigtes Königreich | 5 |
Operativ
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 2 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 3 |
| Electronic Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Technology |
| Private Unternehmen | 3 |
|---|---|
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Health Technology |
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1986 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
| Sterilox Medical Ltd. |
- Börse
- Insiders
- Timothy Cowper
- Erfahrung
